BTCC / BTCC Square / Global Cryptocurrency /
Top Analysts Recommend Biopharma and Biotech Stocks with High Upside Potential

Top Analysts Recommend Biopharma and Biotech Stocks with High Upside Potential

Published:
2025-10-10 14:04:03
28
1
BTCCSquare news:

Wall Street's top analysts have identified Inventiva (IVA) and Nurix Therapeutics (NRIX) as strong buys, citing significant upside potential. Inventiva, a French biopharma firm focused on NASH treatments, holds a consensus 243.58% price target increase across seven analysts. Stifel Nicolaus reaffirmed its $17 target yesterday.

Nurix Therapeutics, developing cancer therapies, received a maintained $27 price target from Needham today. Three other analysts echo the bullish sentiment. These picks emerge as markets show renewed appetite for high-growth biotech plays.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users